| Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans WL Chiou, HY Jeong, SM Chung, TC Wu Pharmaceutical research 17, 135-140, 2000 | 216 | 2000 |
| Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes H Jeong Expert opinion on drug metabolism & toxicology 6 (6), 689-699, 2010 | 178 | 2010 |
| Interindividual variability in cytochrome P450–mediated drug metabolism TS Tracy, AS Chaudhry, B Prasad, KE Thummel, EG Schuetz, X Zhong, ... Drug Metabolism and Disposition 44 (3), 343-351, 2016 | 171 | 2016 |
| Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone SY Choi, KH Koh, H Jeong Drug Metabolism and Disposition 41 (2), 263-269, 2013 | 161 | 2013 |
| Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17β-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy H Chen, K Yang, S Choi, JH Fischer, H Jeong Drug Metabolism and Disposition 37 (9), 1841-1847, 2009 | 150 | 2009 |
| Therapeutic monitoring of mycophenolate mofetil H Jeong, B Kaplan Clinical Journal of the American Society of Nephrology 2 (1), 184-191, 2007 | 146 | 2007 |
| Ten years’ experience with the CYP2D6 activity score: a perspective on future investigations to improve clinical predictions for precision therapeutics A Gaedigk, JC Dinh, H Jeong, B Prasad, JS Leeder Journal of personalized medicine 8 (2), 15, 2018 | 140 | 2018 |
| Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells S Choi, B Sainz Jr, P Corcoran, S Uprichard, H Jeong Xenobiotica 39 (3), 205-217, 2009 | 126 | 2009 |
| Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination H Jeong, S Choi, JW Song, H Chen, JH Fischer Xenobiotica 38 (1), 62-75, 2008 | 119 | 2008 |
| Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites Y Guo, CM Crnkovic, KJ Won, X Yang, JR Lee, J Orjala, H Lee, H Jeong Drug Metabolism and Disposition 47 (3), 194-202, 2019 | 109 | 2019 |
| Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism Y Liu, H Jeong, H Takahashi, K Drozda, SR Patel, NL Shapiro, ... Clinical Pharmacology & Therapeutics 91 (4), 660-665, 2012 | 109 | 2012 |
| Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin … J Gautam, S Banskota, SC Regmi, S Ahn, YH Jeon, H Jeong, SJ Kim, ... Molecular cancer 15, 1-14, 2016 | 91 | 2016 |
| Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy KH Koh, S Jurkovic, K Yang, SY Choi, JW Jung, KP Kim, W Zhang, ... Biochemical pharmacology 84 (1), 93-103, 2012 | 80 | 2012 |
| Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization WL Chiou, HY Jeong, TC Wu, C Ma Clinical Pharmacology & Therapeutics 70 (4), 305-310, 2001 | 77 | 2001 |
| Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy JH Fischer, GE Sarto, J Hardman, L Endres, TM Jenkins, SJ Kilpatrick, ... Clinical pharmacokinetics 53, 373-383, 2014 | 65 | 2014 |
| The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus WS Yeo, R Arya, KK Kim, H Jeong, KH Cho, T Bae Scientific Reports 8 (1), 2521, 2018 | 62 | 2018 |
| Similarity in the linear and non-linear oral absorption of drugs between human and rat. WL Chiou, C Ma, SM Chung, TC Wu, HY Jeong International journal of clinical pharmacology and therapeutics 38 (11), 532-539, 2000 | 60 | 2000 |
| Drug-drug interaction potentials of tyrosine kinase inhibitors via inhibition of UDP-glucuronosyltransferases N Zhang, Y Liu, H Jeong Scientific Reports 5 (1), 17778, 2015 | 59 | 2015 |
| Role of cytochrome P450 genotype in the steps toward personalized drug therapy LH Cavallari, H Jeong, A Bress Pharmacogenomics and personalized medicine, 123-136, 2011 | 57 | 2011 |
| Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screening Z Miller, KS Kim, DM Lee, V Kasam, SE Baek, KH Lee, YY Zhang, L Ao, ... Journal of Medicinal Chemistry 58 (4), 2036-2041, 2015 | 56 | 2015 |
Nina IsoherranenProfessor of Pharmaceutics, University of Washington在 u.washington.edu 的电子邮件经过验证
